The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study-Reference-Cited by-同舟云学术

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

Published:2008-07-27 Issue:2 Volume:116 Page:295-302
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Mook Stella, ,Schmidt Marjanka K.,Viale Giuseppe,Pruneri Giancarlo,Eekhout Inge,Floore Arno,Glas Annuska M.,Bogaerts Jan,Cardoso Fatima,Piccart-Gebhart Martine J.,Rutgers Emiel T.,van’t Veer Laura J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-0130-2.pdf

Reference21 articles.

1. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 63:181–187. doi :10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H

2. Page DL (1991) Prognosis and breast cancer recognition of lethal and favorable prognostic types. Am J Surg Pathol 15:334–349. doi: 10.1097/00000478-199104000-00002

3. Rosen PP, Groshen S, Saigo PE et al (1989) Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 7:1239–1251

4. Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717. doi: 10.1016/S0140-6736(05)66544-0

5. Joensuu H, Pylkkanen L, Toikkanen S (1998) Long-term survival in node-positive breast cancer treated by locoregional therapy alone. Br J Cancer 78:795–799

Cited by 235 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Genomic Testing Help Refine Choosing Wisely the Omission of Axillary Staging in cN0 Breast Cancer?;Journal of Surgical Research;2024-09

2. Genomic Testing to Guide Local Therapy Decisions in Hormone Receptor-Positive Breast Cancer;Current Breast Cancer Reports;2024-03-07

3. Access and barriers to genomic classifiers for breast cancer and prostate cancer in India;International Journal of Cancer;2023-11-14

4. Prediction of the MammaPrint Risk Group Using MRI Features in Women With Estrogen Receptor-Positive, HER2-Negative, and 1 to 3 Node-Positive Invasive Breast Cancer;Clinical Breast Cancer;2023-11

5. Adjuvant chemotherapy for pT1-3N0-1 breast cancer patients with HR+, HER2− subtype: a propensity-score matched study with competing risk analysis;Journal of Cancer Research and Clinical Oncology;2023-07-14